-
1
-
-
0033575930
-
Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14
-
Ames RS, Sarau HM, Chambers JK, Willette RN, Aiyar NV, Romanic AM, Louden CS, Foley JJ, Sauermelch CF, Coatney RW, Ao Z, Disa J, Holmes SD, Stadel JM, Martin JD, Liu WS, Glover GI, Wilson S, Mcnulty DE, Ellis CE, Elshourbagy NA, Shabon U, Trill JJ, Hay DW, Ohlstein EH, Bergsma DJ, Douglas SA: Human urotensin-II is a potent vasoconstrictor and agonist for the orphan receptor GPR14. Nature 401: 282-286, 1999.
-
(1999)
Nature
, vol.401
, pp. 282-286
-
-
Ames, R.S.1
Sarau, H.M.2
Chambers, J.K.3
Willette, R.N.4
Aiyar, N.V.5
Romanic, A.M.6
Louden, C.S.7
Foley, J.J.8
Sauermelch, C.F.9
Coatney, R.W.10
Ao, Z.11
Disa, J.12
Holmes, S.D.13
Stadel, J.M.14
Martin, J.D.15
Liu, W.S.16
Glover, G.I.17
Wilson, S.18
Mcnulty, D.E.19
Ellis, C.E.20
Elshourbagy, N.A.21
Shabon, U.22
Trill, J.J.23
Hay, D.W.24
Ohlstein, E.H.25
Bergsma, D.J.26
Douglas, S.A.27
more..
-
2
-
-
0033660338
-
Endothelin in cardiovascular disease: from atherosclerosis to heart failure
-
Best PJ, Lerman A: Endothelin in cardiovascular disease: from atherosclerosis to heart failure. J Cardiovasc Pharmacol 35: S61-S63, 2000.
-
(2000)
J Cardiovasc Pharmacol
, vol.35
-
-
Best, P.J.1
Lerman, A.2
-
3
-
-
33746062839
-
Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation
-
Bousette N, Hu F, Ohlstein EH, Dhanak D, Douglas SA, Giaid A: Urotensin-II blockade with SB-611812 attenuates cardiac dysfunction in a rat model of coronary artery ligation. J Mol Cell Cardiol 41: 285-295, 2006a.
-
(2006)
J Mol Cell Cardiol
, vol.41
, pp. 285-295
-
-
Bousette, N.1
Hu, F.2
Ohlstein, E.H.3
Dhanak, D.4
Douglas, S.A.5
Giaid, A.6
-
4
-
-
33750066365
-
Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease
-
Bousette N, Pottinger J, Ramli W, Ohlstein EH, Dhanak D, Douglas SA, Giaid A: Urotensin-II receptor blockade with SB-611812 attenuates cardiac remodeling in experimental ischemic heart disease. Peptides 27: 2919-2926, 2006b.
-
(2006)
Peptides
, vol.27
, pp. 2919-2926
-
-
Bousette, N.1
Pottinger, J.2
Ramli, W.3
Ohlstein, E.H.4
Dhanak, D.5
Douglas, S.A.6
Giaid, A.7
-
5
-
-
45849091552
-
Nitric oxide and prostaglandins - important players in endothelin-1 induced myocardial distensibility
-
Brás-Silva C, Monteiro-Sousa D, Duarte AJ, Guerra M, Fontes-Sousa AP, Moura C, Areias JC, Leite Moreira AF: Nitric oxide and prostaglandins - important players in endothelin-1 induced myocardial distensibility. Physiol Res 57: 165-174, 2008.
-
(2008)
Physiol Res
, vol.57
, pp. 165-174
-
-
Brás-Silva, C.1
Monteiro-Sousa, D.2
Duarte, A.J.3
Guerra, M.4
Fontes-Sousa, A.P.5
Moura, C.6
Areias, J.C.7
Leite Moreira, A.F.8
-
6
-
-
0034649248
-
Congestive heart failure: fifty years of progress
-
Braunwald E, Bristow MR: Congestive heart failure: fifty years of progress. Circulation 102 (Suppl IV): 14-23, 2000.
-
(2000)
Circulation
, vol.102
, Issue.SUPPL. IV
, pp. 14-23
-
-
Braunwald, E.1
Bristow, M.R.2
-
7
-
-
3042713965
-
Plasma concentration of urotensin II is raised in hypertension
-
Cheung BM, Leung R, Man YB, Wong LY: Plasma concentration of urotensin II is raised in hypertension. J Hypertens 22: 1341-1344, 2004.
-
(2004)
J Hypertens
, vol.22
, pp. 1341-1344
-
-
Cheung, B.M.1
Leung, R.2
Man, Y.B.3
Wong, L.Y.4
-
8
-
-
0032428160
-
Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord
-
Coulouarn Y, Lihrmann I, Jegou S, Anouar Y, Tostivint H, Beauvillain JC, Conlon JM, Bern HA, Vaudry H: Cloning of the cDNA encoding the urotensin II precursor in frog and human reveals intense expression of the urotensin II gene in motoneurons of the spinal cord. Proc Natl Acad Sci USA 95: 15803-15808, 1998.
-
(1998)
Proc Natl Acad Sci USA
, vol.95
, pp. 15803-15808
-
-
Coulouarn, Y.1
Lihrmann, I.2
Jegou, S.3
Anouar, Y.4
Tostivint, H.5
Beauvillain, J.C.6
Conlon, J.M.7
Bern, H.A.8
Vaudry, H.9
-
9
-
-
1242272211
-
Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker)
-
Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP: Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker). Int J Cardiol 93: 105-111, 2004.
-
(2004)
Int J Cardiol
, vol.93
, pp. 105-111
-
-
Dimopoulos, K.1
Salukhe, T.V.2
Coats, A.J.3
Mayet, J.4
Piepoli, M.5
Francis, D.P.6
-
10
-
-
0037042532
-
Congestive heart failure and expression of myocardial urotensin II
-
Douglas SA, Tayara L, Ohlstein EH, Halawa N, Giaid A: Congestive heart failure and expression of myocardial urotensin II. Lancet 359: 1990-1997, 2002.
-
(2002)
Lancet
, vol.359
, pp. 1990-1997
-
-
Douglas, S.A.1
Tayara, L.2
Ohlstein, E.H.3
Halawa, N.4
Giaid, A.5
-
11
-
-
31344435173
-
Urotensin-II expression in the mouse spinal cord
-
Egginger JG, Camus A, Calas A: Urotensin-II expression in the mouse spinal cord. J Chem Neuroanat 31: 146-154, 2006.
-
(2006)
J Chem Neuroanat
, vol.31
, pp. 146-154
-
-
Egginger, J.G.1
Camus, A.2
Calas, A.3
-
12
-
-
38449119600
-
Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling
-
Fontes-Sousa AP, Brás-Silva C, Pires AL, Monteiro-Sousa D, Leite-Moreira AF: Urotensin II acutely increases myocardial length and distensibility: potential implications for diastolic function and ventricular remodeling. Naunyn-Schmiedebergs Arch Pharmacol 376: 107-115, 2007.
-
(2007)
Naunyn-Schmiedebergs Arch Pharmacol
, vol.376
, pp. 107-115
-
-
Fontes-Sousa, A.P.1
Brás-Silva, C.2
Pires, A.L.3
Monteiro-Sousa, D.4
Leite-Moreira, A.F.5
-
13
-
-
33746276776
-
Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers
-
Gruson D, Rousseau MF, Ahn SA, Van Linden F, Ketelslegers JM: Circulating urotensin II levels in moderate to severe congestive heart failure: its relations with myocardial function and well established neurohormonal markers. Peptides 27: 1527-1531, 2006.
-
(2006)
Peptides
, vol.27
, pp. 1527-1531
-
-
Gruson, D.1
Rousseau, M.F.2
Ahn, S.A.3
Van Linden, F.4
Ketelslegers, J.M.5
-
14
-
-
3142634520
-
The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease
-
Heringlake M, Kox T, Uzun O, Will B, Bahlmann L, Klaus S, Eleftheriadis S, ARMBRUSTER FP, Franz N, Kraatz E: The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease. Regul Pept 121: 129-136, 2004.
-
(2004)
Regul Pept
, vol.121
, pp. 129-136
-
-
Heringlake, M.1
Kox, T.2
Uzun, O.3
Will, B.4
Bahlmann, L.5
Klaus, S.6
Eleftheriadis, S.7
Armbruster, F.P.8
Franz, N.9
Kraatz, E.10
-
15
-
-
0030737958
-
Endothelins and cardiac hypertrophy
-
ITO H: Endothelins and cardiac hypertrophy. Life Sci 61: 585-593, 1997.
-
(1997)
Life Sci
, vol.61
, pp. 585-593
-
-
Ito, H.1
-
16
-
-
11144313355
-
Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators
-
Johns DG, Ao Z, Naselsky D, Herold CL, Maniscalco K, Sarov-Blat L, Steplewski K, Aiyar N, Douglas SA: Urotensin-II-mediated cardiomyocyte hypertrophy: effect of receptor antagonism and role of inflammatory mediators. Naunyn-Schmiedebergs Arch Pharmacol 370: 238-250, 2004.
-
(2004)
Naunyn-Schmiedebergs Arch Pharmacol
, vol.370
, pp. 238-250
-
-
Johns, D.G.1
Ao, Z.2
Naselsky, D.3
Herold, C.L.4
Maniscalco, K.5
Sarov-Blat, L.6
Steplewski, K.7
Aiyar, N.8
Douglas, S.A.9
-
18
-
-
33645096367
-
+ exchanger-mediated effect
-
+ exchanger-mediated effect. Br J Pharmacol 147: 690-697, 2006.
-
(2006)
Br J Pharmacol
, vol.147
, pp. 690-697
-
-
Leite-Moreira, A.F.1
Castro-Chaves, P.2
Pimentel-Nunes, P.3
Lima-Carneiro, A.4
Guerra, M.S.5
Soares, J.B.6
Ferreira-Martins, J.7
-
19
-
-
33644865034
-
Serotonin transporter mechanisms and cardiac disease
-
Levy RJ: Serotonin transporter mechanisms and cardiac disease. Circulation 113: 2-4, 2006.
-
(2006)
Circulation
, vol.113
, pp. 2-4
-
-
Levy, R.J.1
-
20
-
-
22044453982
-
Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II
-
Li J, Wang J, Russell FD, Molenaar P: Activation of calcineurin in human failing heart ventricle by endothelin-1, angiotensin II and urotensin II. Br J Pharmacol 145: 432-440, 2005.
-
(2005)
Br J Pharmacol
, vol.145
, pp. 432-440
-
-
Li, J.1
Wang, J.2
Russell, F.D.3
Molenaar, P.4
-
21
-
-
0030707732
-
Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs
-
Miyahara T, Shibamoto T, Wang HG, Koyama S: Role of circulating blood components and thromboxane in anaphylactic vasoconstriction in isolated canine lungs. J Appl Physiol 83: 1508-1516, 1997.
-
(1997)
J Appl Physiol
, vol.83
, pp. 1508-1516
-
-
Miyahara, T.1
Shibamoto, T.2
Wang, H.G.3
Koyama, S.4
-
22
-
-
0037016037
-
Plasma urotensin in human systolic heart failure
-
Ng LL, Loke I, O'brien RJ, Squire IB, Davies JE: Plasma urotensin in human systolic heart failure. Circulation 106: 2877-2880, 2002.
-
(2002)
Circulation
, vol.106
, pp. 2877-2880
-
-
Ng, L.L.1
Loke, I.2
O'brien, R.J.3
Squire, I.B.4
Davies, J.E.5
-
23
-
-
0025266820
-
Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications
-
Pfeffer MA, Braunwald E: Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications. Circulation 81: 1161-1172, 1990.
-
(1990)
Circulation
, vol.81
, pp. 1161-1172
-
-
Pfeffer, M.A.1
Braunwald, E.2
-
24
-
-
0037125572
-
Plasma urotensin II in heart failure
-
Richards AM, Nicholls MG, Lainchbury JG, Fisher S, Yandle TG: Plasma urotensin II in heart failure. Lancet 360: 545-546, 2002.
-
(2002)
Lancet
, vol.360
, pp. 545-546
-
-
Richards, A.M.1
Nicholls, M.G.2
Lainchbury, J.G.3
Fisher, S.4
Yandle, T.G.5
-
25
-
-
4644306988
-
Emerging roles of urotensin-II in cardiovascular disease
-
Russell FD: Emerging roles of urotensin-II in cardiovascular disease. Pharmacol Ther 103: 223-243, 2004.
-
(2004)
Pharmacol Ther
, vol.103
, pp. 223-243
-
-
Russell, F.D.1
-
26
-
-
0141788726
-
Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure
-
Russell FD, Meyers D, Galbraith AJ, Bett N, Toth I, Kearns P, Molenaar P: Elevated plasma levels of human urotensin-II immunoreactivity in congestive heart failure. Am J Physiol 285: H1576-H1581, 2003.
-
(2003)
Am J Physiol
, vol.285
-
-
Russell, F.D.1
Meyers, D.2
Galbraith, A.J.3
Bett, N.4
Toth, I.5
Kearns, P.6
Molenaar, P.7
-
27
-
-
4043056592
-
Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart
-
Russell FD, Molenaar P: Investigation of signaling pathways that mediate the inotropic effect of urotensin-II in human heart. Cardiovasc Res 63: 673-681, 2004.
-
(2004)
Cardiovasc Res
, vol.63
, pp. 673-681
-
-
Russell, F.D.1
Molenaar, P.2
-
28
-
-
0034644865
-
Human urotensin II mediates vasoconstriction via an increase in inositol phosphates
-
Saetrum Opgaard O, Nothacker H, Ehlert FJ, Krause DN: Human urotensin II mediates vasoconstriction via an increase in inositol phosphates. Eur J Pharmacol 406: 265-271, 2000.
-
(2000)
Eur J Pharmacol
, vol.406
, pp. 265-271
-
-
Saetrum Opgaard, O.1
Nothacker, H.2
Ehlert, F.J.3
Krause, D.N.4
-
29
-
-
0035827716
-
Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase
-
Sauzeau V, LE Mellionnec E, Bertoglio J, Scalbert E, Pacaud P, Loirand G: Human urotensin II-induced contraction and arterial smooth muscle cell proliferation are mediated by RhoA and Rho-kinase. Circ Res 88: 1102-1104, 2001.
-
(2001)
Circ Res
, vol.88
, pp. 1102-1104
-
-
Sauzeau, V.1
Le Mellionnec, E.2
Bertoglio, J.3
Scalbert, E.4
Pacaud, P.5
Loirand, G.6
-
30
-
-
33748195575
-
Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells
-
Shi L, Ding W, Li D, Wang Z, Jiang H, Zhang J, Tang C: Proliferation and anti-apoptotic effects of human urotensin II on human endothelial cells. Atherosclerosis 188: 260-264, 2006.
-
(2006)
Atherosclerosis
, vol.188
, pp. 260-264
-
-
Shi, L.1
Ding, W.2
Li, D.3
Wang, Z.4
Jiang, H.5
Zhang, J.6
Tang, C.7
-
31
-
-
0037165228
-
Angiotensin II and trials of cardiovascular outcomes
-
Sleight P: Angiotensin II and trials of cardiovascular outcomes. Am J Cardiol 89: 11A-17A, 2002.
-
(2002)
Am J Cardiol
, vol.89
-
-
Sleight, P.1
-
32
-
-
33846461155
-
Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension
-
Suguro T, Watanabe T, Ban Y, Kodate S, Misaki A, Hirano T, Miyazaki A, Adachi M: Increased human urotensin II levels are correlated with carotid atherosclerosis in essential hypertension. Am J Hypertens 20: 211-217, 2007.
-
(2007)
Am J Hypertens
, vol.20
, pp. 211-217
-
-
Suguro, T.1
Watanabe, T.2
Ban, Y.3
Kodate, S.4
Misaki, A.5
Hirano, T.6
Miyazaki, A.7
Adachi, M.8
-
33
-
-
2342656463
-
Mechanism of human urotensin II-induced contraction in rat aorta
-
Tasaki K, Hori M, Ozaki H, Karaki H, Wakabayashi I: Mechanism of human urotensin II-induced contraction in rat aorta. J Pharmacol Sci 94: 376-383, 2004.
-
(2004)
J Pharmacol Sci
, vol.94
, pp. 376-383
-
-
Tasaki, K.1
Hori, M.2
Ozaki, H.3
Karaki, H.4
Wakabayashi, I.5
-
34
-
-
0042525995
-
Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy
-
Tzanidis A, Hannan RD, Thomas WG, Onan D, Autelitano DJ, See F, Kelly DJ, Gilbert RE, Krum H: Direct actions of urotensin II on the heart: implications for cardiac fibrosis and hypertrophy. Circ Res 93: 246-253, 2003.
-
(2003)
Circ Res
, vol.93
, pp. 246-253
-
-
Tzanidis, A.1
Hannan, R.D.2
Thomas, W.G.3
Onan, D.4
Autelitano, D.J.5
See, F.6
Kelly, D.J.7
Gilbert, R.E.8
Krum, H.9
-
35
-
-
12244302212
-
Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack
-
Ueyama T, Senba E, Kasamatsu K, Hano T, Yamamoto K, Nishio I, Tsuruo Y, Yoshida K: Molecular mechanism of emotional stress-induced and catecholamine-induced heart attack. J Cardiovasc Pharmacol 41 (Suppl 1): S115-S118, 2003.
-
(2003)
J Cardiovasc Pharmacol
, vol.41
, Issue.SUPPL. 1
-
-
Ueyama, T.1
Senba, E.2
Kasamatsu, K.3
Hano, T.4
Yamamoto, K.5
Nishio, I.6
Tsuruo, Y.7
Yoshida, K.8
-
36
-
-
33846188981
-
Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction
-
Wang YX, Ding YJ, Zhu YZ, Shi Y, Yao T, Zhu YC: Role of PKC in the novel synergistic action of urotensin II and angiotensin II and in urotensin II-induced vasoconstriction. Am J Physiol 292: H348-H359, 2007.
-
(2007)
Am J Physiol
, vol.292
-
-
Wang, Y.X.1
Ding, Y.J.2
Zhu, Y.Z.3
Shi, Y.4
Yao, T.5
Zhu, Y.C.6
-
37
-
-
33746319906
-
Human urotensin II as a link between hypertension and coronary artery disease
-
Watanabe T, Kanome T, Miyazaki A, Katagiri T: Human urotensin II as a link between hypertension and coronary artery disease. Hypertens Res 29: 375-387, 2006.
-
(2006)
Hypertens Res
, vol.29
, pp. 375-387
-
-
Watanabe, T.1
Kanome, T.2
Miyazaki, A.3
Katagiri, T.4
-
38
-
-
0035800017
-
Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells
-
Watanabe T, Pakala R, Katagiri T, Benedict CR: Synergistic effect of urotensin II with mildly oxidized LDL on DNA synthesis in vascular smooth muscle cells. Circulation 104: 16-18, 2001a.
-
(2001)
Circulation
, vol.104
, pp. 16-18
-
-
Watanabe, T.1
Pakala, R.2
Katagiri, T.3
Benedict, C.R.4
-
39
-
-
0035208577
-
Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation
-
Watanabe T, Pakala R, Katagiri T, Benedict CR: Synergistic effect of urotensin II with serotonin on vascular smooth muscle cell proliferation. J Hypertens 19: 2191-2196, 2001b.
-
(2001)
J Hypertens
, vol.19
, pp. 2191-2196
-
-
Watanabe, T.1
Pakala, R.2
Katagiri, T.3
Benedict, C.R.4
-
40
-
-
0028156774
-
Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms
-
Weber H, Webb ML, Serafino R, Taylor DS, Moreland S, Norman J, Molloy CJ: Endothelin-1 and angiotensin-II stimulate delayed mitogenesis in cultured rat aortic smooth muscle cells: evidence for common signaling mechanisms. Mol Endocrinol 8: 148-158, 1994.
-
(1994)
Mol Endocrinol
, vol.8
, pp. 148-158
-
-
Weber, H.1
Webb, M.L.2
Serafino, R.3
Taylor, D.S.4
Moreland, S.5
Norman, J.6
Molloy, C.J.7
-
41
-
-
33749371071
-
The role of urotensin II in cardiovascular and renal physiology and diseases
-
Zhu YC, Zhu YZ, Moore PK: The role of urotensin II in cardiovascular and renal physiology and diseases. Br J Pharmacol 148: 884-901, 2006.
-
(2006)
Br J Pharmacol
, vol.148
, pp. 884-901
-
-
Zhu, Y.C.1
Zhu, Y.Z.2
Moore, P.K.3
|